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Constitutively bound CTCF sites maintain 3D
chromatin architecture and long-range
epigenetically regulated domains
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The architectural protein CTCF is a mediator of chromatin conformation, but how CTCF
binding to DNA is orchestrated to maintain long-range gene expression is poorly understood.
Here we perform RNAi knockdown to reduce CTCF levels and reveal a shared subset of
CTCF-bound sites are robustly resistant to protein depletion. The ‘persistent’ CTCF sites are
enriched at domain boundaries and chromatin loops constitutive to all cell types. CRISPR-
Cas9 deletion of 2 persistent CTCF sites at the boundary between a long-range epigenetically
active (LREA) and silenced (LRES) region, within the Kallikrein (KLK) locus, results in con-
cordant activation of all 8 KLK genes within the LRES region. CTCF genome-wide depletion
results in alteration in Topologically Associating Domain (TAD) structure, including the
merging of TADs, whereas TAD boundaries are not altered where persistent sites are
maintained. We propose that the subset of essential CTCF sites are involved in cell-type
constitutive, higher order chromatin architecture.
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Three-dimensional (3D) chromatin conformation is animportant regulator of gene expression as it affects whichregulatory elements come into contact with gene pro-
moters, and thus which genes are activated and which are
repressed1. Hi-C allows simultaneous capture of all chromatin
interactions occurring across the genome in a single experiment and
has revealed that chromatin interactions are compartmentalised
into topologically associated domains (TADs)2,3. TADs are ~1Mb
sized, contiguous chromosomal regions with insulated boundaries.
This organisation facilitates a high frequency of interaction for loci
located within a TAD and little interaction between TADs1,2. TADs
are reportedly conserved across cell types2,4,5. A vast amount of
research has established CCCTC-binding factor (CTCF) as a
mediator of chromatin looping6,7 and TAD boundary insulation8,9.
In addition to these mechanisms, CTCF can also insulate between
regions of active chromatin marked by H3K4me3 and repressive
regions marked by H3K27me3 to prevent aberrant spreading of
either chromatin mark into its opposing state10,11.
However, several studies have yielded inconsistent results on
the role of CTCF in long-range chromatin interactions and in the
maintenance of TAD boundaries. For example it has been
reported that CRISPR-Cas9 depletion of CTCF located at can-
didate TAD boundaries is sufficient to deplete the targeted
boundary8,11 and conversely, that TAD boundaries remain intact
following loss of CTCF12. Moreover, a CTCF siRNA approach in
HEK293T cells reported a general maintenance of TAD bound-
aries and modest changes to gene expression13, whereas, a more
recent study that utilised the auxin-inducible degron (AID) sys-
tem to directly target CTCF protein for degradation (as opposed
to targeting mRNA) in mouse embryonic stem cells observed
complete loss of insulation at 80% of TAD boundaries14. Taken
together, these studies demonstrate that the consequences of
CTCF depletion on 3D architecture are still unclear.
We previously reported long-range epigenetic silencing
(LRES)15 and activation (LREA)16 in prostate cancer. In LRES,
regions of chromatin concordantly lose active histone marks and
gain repressive histone marks in cancer cells, which results in the
underlying genes becoming silenced. In contrast to this, in LREA,
regions of chromatin concordantly lose repressive histone marks
and gain active histone marks in cancer cells and undergo gene
activation. One long-range deregulated region of interest in
prostate cancer is located on chr19—51,322,404–51,587,502
(hg19). This locus is ~270 kb in size and contains all members of
the Kallikrein (KLK) serine-protease gene family, including KLK3,
which encodes prostate-specific antigen (PSA),17,18 and KLK4,
which is implicated as a mediator of mTOR signalling in prostate
cancer19. Intriguingly, KLK3 and KLK4, as well as KLK1, KLK15,
KLK2, KLKP1 are contained within a LREA region in prostate
cancer cells, which is immediately adjacent to an LRES region
harbouring KLK5, KLK6, KLK7, KLK8, KLK9, KLK10, KLK11,
KLK12, KLK13 and KLK14 genes. We were therefore motivated to
determine if CTCF sites bounded the border of the LREA and
LRES regions at this locus.
Here, we explore the genome-wide chromatin effects of global
CTCF depletion and CRISPR-targeted CTCF deletion to deter-
mine the involvement of CTCF in compartmentalisation of the
long-range epigenetically regulated regions. We show that there is
a subset of CTCF sites, that are resistant to CTCF depletion and
propose these persistent CTCF sites are essential for cell-type
constitutive higher order chromatin architecture and the main-
tenance of long-range epigenetically regulated domains.
Results
The Kallikrein locus is bordered by CTCF-binding sites. The
Kallikrein (KLK) gene locus is comprised of an LREA region,
immediately adjacent to a LRES region (Fig. 1). Given the discrete
compartmentalisation of gene expression at the KLK locus and
the well-established role of CTCF as an insulator of functional
domains11,20,21, we were interested to determine if CTCF binding
was associated with the demarcation of the active and repressive
domains. We analysed CTCF ChIP-seq data for normal prostate
cells (PrEC) and prostate cancer cell line (LNCaP)16 and found
that the CTCF-binding pattern was strikingly similar across the
locus regardless of the different expression profiles. Both normal
and cancer cells harboured two discrete CTCF-binding sites at the
boundary of the active and repressive regions, as well as CTCF
sites throughout the flanking domains (Fig. 1).
To next evaluate the chromatin structure at this locus we
performed Chromosome Conformation Capture (3C)22 using a
fragment containing one of the two CTCF sites at the boundary of
the active LREA and repressive LRES regions, indicated in Fig. 2a,
as bait. We found two interactions; one occurred 149.2 kb
upstream of the bait and the other 163.8 kb downstream from the
bait (Fig. 2a, Supplementary Fig. 1a). These interactions were also
verified by performing reciprocal 3C using the long-range
flanking interacting fragments as baits (Fig. 2b, c; Supplementary
Fig. 1b, c). However in comparison to the strong interaction
between the fragments located at 149.2 and 163.8 kb from the
LRES/LREA boundary there is relatively little interaction between
the outer borders of the KLK domains. Together this data
demonstrates that discrete chromatin loops spatially separate the
LREA and LRES regions across the KLK gene locus at the
boundary of CTCF sites. CTCF-binding motifs flanking chroma-
tin loops mostly have a convergent orientation4,23. The down-
stream loop at the KLK locus has anchors with convergent CTCF
motifs, however the upstream loop is potentially anchored by
divergent CTCF motifs (Fig. 1).
CTCF depletion does not lead to widespread gene activation.
As CTCF has been reported to act as a barrier to the spreading of
active and repressive marks11,24,25, we assessed whether loss of
CTCF results in gene expression and chromatin modification
alterations both genome-wide and at the KLK gene locus. We
depleted CTCF in LNCaP cells with a siRNA pool (4 siRNAs/
pool) and showed robust depletion (≥90%) of CTCF mRNA by
qRT-PCR (Fig. 3a) and protein by western blot (Fig. 3b) at both
72 and 144 h post-transfection. We first measured global changes
to gene expression at 24, 72 and 144 h post CTCF-siRNA
transfection using an Affymetrix GeneChip® Human Gene 2.0 ST
Array. After 24 h only CTCF mRNA was significantly down
regulated. At 72 and 144 h there were 17 and 663 genes (1.9% of
total on array) that showed altered expression, respectively
(Fig. 3c). We found that 15/17 genes at 72 h had CTCF bound at
their promoter prior to transfection and of these, 15/15 lost CTCF
binding following RNAi treatment. At 144 h, 155/663 had CTCF
bound at their promoters prior to transfection and 145/155 lost
binding following RNAi. However, there was no significant
change to gene expression across the KLK LREA/LRES regions
(Fig. 3d). We performed 3C following CTCF knockdown to assess
if there were any changes to looping at the KLK locus. Loss of
CTCF did not lead to the formation of new contacts in the region.
However, on average we saw 16.9% and 36.3% reduction in
interaction strength between the bait fragment and its upstream
and downstream targets, respectively (Supplementary Fig. 2)
suggesting that the lost CTCF sites are less critical for the loop
formation and gene expression control at the KLK locus.
We next performed H3K4me3 and H3K27ac ChIP-seq
following 144 h of CTCF RNAi treatment. We found that there
was no significant change to the active histone marks across the
KLK LREA/LRES regions (Fig. 3e), and only a small proportion of
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H3K27ac peaks (1773/55,700) and H3K4me3 (193/12,037) peaks
genome-wide were significantly altered in the control versus
CTCF RNAi cells (Fig. 3f). Therefore, our results show that CTCF
depletion does not lead to widespread ectopic gene activation or
chromatin modification changes.
CTCF-binding sites resistant to CTCF depletion. Due to the
modest molecular changes identified after CTCF knockdown we
next performed CTCF ChIP-seq, following 144 h of CTCF RNAi
treatment, to determine if the apparent robust mRNA and pro-
tein depletion of CTCF (Fig. 3a, b) was sufficient to result in
direct loss of CTCF binding to chromatin genome-wide. Intri-
guingly, we found that out of the 25,617 CTCF ChIP-seq bound
sites, ~11.6% (2973/25,617) retained significant and persistent
binding following treatment with CTCF siRNA in comparison to
only 49 CTCF sites that were gained (Fig. 4a). ‘Persistent’ CTCF
sites were defined as sites that were maintained across wild-type,
control RNAi and the CTCF RNAi biological replicates. In con-
trast, ‘lost’ CTCF sites were defined as sites that were absent in the
CTCF RNAi biological replicates, relative to the wild-type and
control RNAi cells (Supplementary Fig. 3a). Example loci that
demonstrate both lost and persistent CTCF sites are shown
(Fig. 4b and Supplementary Fig. 3b). Notably, we found that the
majority of the CTCF sites were lost across the KLK gene locus in
LNCaP cells following RNAi treatment, with the exception of two
persistent CTCF sites located at the border of the LREA/LRES
regions (Fig. 4c), which we confirmed were maintained by ChIP-
qPCR (Supplementary Fig. 3c). Since the cohesin complex has
been established to co-bind at CTCF sites in a CTCF-dependent
manner26, we also assessed if cohesin binding was associated with
lost or persistent CTCF sites. We performed ChIP-qPCR for the
cohesin subunit, RAD21, at the KLK locus following 144 h of
CTCF RNAi. Our results demonstrate that RAD21 binding was
reduced where CTCF binding was lost and was retained at the
two internal border persistent CTCF sites (two-tailed t-test, p <
0.05) (Fig. 4c).
CRISPR of persistent CTCF-binding sites at KLK locus. To
investigate if the two persistent boundary CTCF sites at the KLK
locus were important in the maintenance of the functional
demarcation of the LREA and LRES regions, we employed
CRISPR-Cas9n27 to delete these CTCF-binding motifs (location
of guide RNAs are featured in Supplementary Fig. 4). We
achieved an 80.2% depletion of CTCF binding at the upstream
motif (two-tailed t-test, p < 0.0001) and 47.8% depletion at the
downstream motif (two-tailed t-test, p= 0.0002) as measured by
CTCF ChIP-qPCR (Fig. 5a). Importantly, binding at the
remaining CTCF motifs in the KLK region was unchanged. We
also performed a RAD21 ChIP-qPCR and found that RAD21
binding was lost at the two CRISPR sites, but retained at all other
CTCF sites across the region (Fig. 5b). We next assessed if there
were expression changes to the KLK genes within the LREA and
LRES regions following CRISPR-Cas9n using qRT-PCR. We
found no change in gene expression within the LREA loop,
whereas there was coordinate up regulation of all the KLK genes
within the LRES region (Fig. 5c and Supplementary Fig. 5).
51,300,000 51,400,000 51,500,000 51,600,000
chr19 (q13.33-q13.41)
R
N
A
H
3K
9a
c
H
3K
27
m
e3
H
3K
4m
e3
CT
CF
LNCaP
PreC
LNCaP
PreC
LNCaP
PreC
LNCaP
PreC
LNCaP
PreC
KL
K1
KL
K1
5
GP
R3
2
AC
PT
KL
K3
KL
K2
KL
KP
1
KL
K4
KL
K5
BO
UN
DA
RY
KL
K6
KL
K7
KL
K8
KL
K9
KL
K1
0
KL
K1
1
KL
K1
2
KL
K1
3
CT
U1
KL
K1
4
0
3
0
3
0
2
0
2
0
3
0
3
0
.5
0
.5
0
50
0
50
LREA LRES
Fig. 1 Epigenome map of the Kallikrein locus in prostate cells. RNA-seq and ChIP-seq (H3K27me3, H3K9ac, H3K4me3 and CTCF) profiles of adjacent,
transcriptionally active (green highlight) and silenced (red highlight) regions in LNCaP cancer cell line and normal PrEC cells. CTCF ChIP-seq shows CTCF
binding throughout the locus. Two CTCF sites are located at the boundary between the active and silenced regions.
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To determine if the gene activation was accompanied by a
change in chromatin conformation, we performed 3C on the
CTCF–CRISPR–Cas9n and non-targeting CRISPR–Cas9n con-
trol cells in biological duplicate experiments (Fig. 5d and
Supplementary Fig. 6a, b). On average a 66.1% reduction in
chromatin interaction strength was observed, in the 3C replicates,
between the bait and its downstream interacting fragment for the
LRES loop containing the up-regulated genes with a lesser change
to the LREA loop (12.6% reduction) (Fig. 5d and Supplementary
Fig. 6a, b). In addition there is no change in weak chromatin
interactions observed at the outer borders of the LRES/LREA
regions (Supplementary Fig. 6c). Taken together these results
show that the removal of the region harbouring the persistent
CTCF sites at the boundary of the LREA/LRES regions results in
opening of the downstream chromatin loop and activation of the
entire LRES domain, as summarised in the schematic in Fig. 5e.
Persistent CTCF sites show stronger binding intensity. To
explore the characteristics of lost and persistent CTCF-binding
sites genome-wide we first asked if persistent CTCF sites display
more prominent CTCF binding prior to siRNA treatment, which
could explain greater maintenance of CTCF binding-signal after
knockdown. To address this we divided the CTCF ChIP-seq data
for wild-type LNCaP cells into two categories: (1) lost following
CTCF RNAi or (2) persistent following CTCF RNAi. We then
plotted the average CTCF ChIP-seq signal at CTCF-binding sites,
which revealed that on average persistent sites have stronger
binding intensity than lost sites (two-tailed t-test, p < 0.0001)
(Supplementary Fig. 7a). Given the nature of ChIP-seq data this
result can also be interpreted as these sites being bound in more
cells in the population. A heat map displaying the binding
intensity at each CTCF site individually revealed that a propor-
tion of lost sites also have a binding intensity equivalent to the
persistent sites, which indicates that binding intensity is not the
only factor contributing to CTCF stability after siRNA treatment
(Supplementary Fig. 7b). It was previously reported that CTCF
sites with the highest binding affinity have a CTCF-binding motif
that is closer in sequence to the CTCF consensus motif28. We
used HOMER to search for the frequency of CTCF consensus
motifs in lost and persistent CTCF sites. In agreement with the
literature this revealed that the consensus motif was identified in a
greater proportion of persistent sites 2556/2949 (85.9%) than lost
sites 13,475/22,644 (59.5%).
DNA methylation of the CTCF-binding motif has been shown
to prevent the binding of CTCF29,30. Hence we asked whether
there was a difference in the levels of average DNA methylation
between the lost and persistent CTCF subsets. To assess the
methylation status and DNA accessibility we analysed NOMe-seq
data from wild-type LNCaP cells31. We divided the methylome
data based on whether the CTCF sites had lost or persistent
binding following CTCF RNAi. The CpG methylation values at
each of the subclasses of CTCF sites revealed that persistent
binding sites in general are less methylated than lost CTCF sites
(Supplementary Fig. 8a). The 1-GpC methylation (measure of
nucleosome occlusion) highlighted that the DNA immediately
surrounding persistent CTCF sites are less occluded by nucleo-
somes and thus are more accessible for CTCF binding than the
DNA surrounding the lost CTCF sites. To next compare
persistent and lost CTCF peaks with similar high CTCF levels
we analysed the subset of lost CTCF sites with the highest CTCF
levels (2973) to an equal number of persistent sites. We found
that the CpG methylation levels are equivalent at the strongly
bound CTCF sites and accessibility is also similar between the two
groups. However peak height at the CTCF-binding site is more
pronounced for persistent sites, which suggests that these sites are
more consistently bound across a population of cells (Supple-
mentary Fig. 8b).
Persistent CTCF sites are enriched at TAD boundaries. To
assess the effect of CTCF depletion on three-dimensional chro-
matin conformation across the genome we performed Hi-C
experiments with 40 kb resolution in LNCaP cells following 144 h
of transfection with control and CTCF siRNA. We first analysed
gross changes to the TAD structure by determining the total
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Fig. 2 3D structure of the KLK locus compartmentalises expression
domains. a 3C-qPCR at the KLK locus. Bars above the graph illustrate BglII
fragments across the region. The 3C bait fragment is indicated by the
yellow bar and interacting fragments are shown by red lines (149.2 kb
upstream from bait, 163.8 kb downstream from bait). The pink arrows
indicate the direction of CTCF motifs. The dotted arrows demonstrate the
loops indicated by the interaction data. Error bars represent standard error
(SE). b As in a, utilising upstream interacting fragment from a as bait.
Interacting fragments are 143.2 and 313.0 kb downstream from the bait.
c As in a, utilising downstream interacting fragment from a as bait.
Interacting fragments are 68.9, 169.8 and 313.0 kb upstream from the bait.
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amount of the genome compartmentalised into TADs before and
after CTCF siRNA knockdown. We found that a similar amount
of the genome was packaged within TADs for the control and
knockdown conditions (2.64 and 2.58 Gb, respectively). In the
control condition, 2864 TADs were called with a median size of
720 kb. Interestingly the CTCF RNAi-treated cells contained less
TADs (2389) with a larger median size of 840 kb (Supplementary
Fig. 9).
To further explore the nature of TAD alterations following
CTCF depletion we intersected TAD boundaries from the control
and knockdown conditions and found that the majority of TAD
boundaries, 2057/2609 (~79%) were maintained after CTCF
siRNA treatment. Approximately 33% (1022/3079) were lost
from the control cells and interestingly, 21% (552/2609) new
TAD boundaries were identified in the CTCF siRNA knockdown
cells (Fig. 6a). Moreover intersection of control and CTCF RNAi
TADs revealed that 416 (14.5%) TADs in control cells became
merged into larger TADs in the CTCF knockdown cells which is
represented schematically in Fig. 6b. This is consistent with the
smaller number of larger sized TADs suggesting that CTCF
depletion results in merging of TADs due to loss of insulation. In
comparison only 160 (6.7%) new smaller TADs were identified.
Examples of merged TADs and subdivided TADs following
CTCF siRNA knockdown are shown in Fig. 6c and d and
Supplementary Fig. 10a, b. Notably maintained TAD boundaries
after CTCF depletion overlapped with the location and main-
tenance of persistent CTCF-binding sites (example shown in
Fig. 6c). A positional enrichment graph showing the distribution
of lost and persistent CTCF peaks at maintained TAD boundaries
confirmed the genome-wide enrichment for persistent CTCF site
binding at these loci (two-tailed t-test, p < 0.0001) (Fig. 6e). These
results are consistent with a role for persistent CTCF sites in
insulation of TAD boundaries from perturbation.
Persistent CTCF sites and constitutive chromatin architecture.
Since CTCF binding can be cell-type specific, common to mul-
tiple cell types, or cell-type constitutive32, we next asked if per-
sistent sites were also conserved in other cell types and associated
with chromatin architecture. We analysed kilobase resolution Hi-
C data for eight diverse cell types—GM12878, K562, HeLA,
IMR90, HUVEC, NHEK, HMEC and KBM74 and the corre-
sponding CTCF ChIP-seq data sets for each of these cell types.
Remarkably, we found that 97.7% of all the persistent CTCF sites
were constitutively bound across all eight diverse cell types, in
comparison to 67.5% of lost CTCF sites (Fig. 7a). Figure 7b shows
an example of conservation of persistent sites across all cell types.
To investigate if the persistent CTCF sites identified in the cancer
LNCaP cells were also persistent in an unrelated cell type we
performed CTCF knockdown in normal IMR90 cells and
achieved ~80% knockdown of CTCF mRNA (Supplementary
Fig. 11a). Notably we showed the majority of persistent CTCF
sites in IMR90 cells (87.3%) overlapped with the LNCaP-
persistent sites (Fig. 7c). Given this ubiquitous binding in
human cell lines, we next used PhastCons33 to determine the level
of evolutionarily conservation of the CTCF-binding sites in the
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lost and persistent subsets. This analysis showed a much greater
level of sequence conservation for the persistent CTCF-binding
sites (Supplementary Fig. 11b). We also found a significant over-
representation of persistent CTCF sites versus lost sites at domain
boundaries in the eight diverse cell types. (Fig. 7d). Given the
strong conservation of persistent sites, we next asked whether
persistent sites were more enriched at cell-type constitutive
domains. We divided all domain boundaries into: (1) cell-type
specific (one cell type), (2) common to more than one cell type
(2–7 seven cell types), or (3) constitutively present in all cell types
(8 cell types) and created positional enrichment plots to overlay
the distribution of LNCaP lost and persistent CTCF at the
boundaries of each subset (Fig. 7e). We found that lost CTCF-
binding sites were prevalent at cell-type-specific domains and the
binding intensity decreased, as domains became more cell-type
ubiquitous. In contrast, persistent CTCF site binding was deplete
at cell-type-specific domains and increased in intensity at cell-
type constitutive chromatin domains (two-tailed t-test, p= 0.02).
We performed the same analysis on cell-type specific, cell- type
common and cell- type constitutive chromatin loops and con-
firmed that persistent sites are also enriched at constitutive
chromatin loops (Supplementary Fig. 11c).
TAD boundaries are enriched for housekeeping genes2. We
therefore hypothesised that the cell-type constitutive boundaries
identified above would be more enriched for housekeeping genes
than cell-type specific or cell-type common boundaries (present
in 2–7 cell types). We measured the fold enrichment of
housekeeping genes at domain boundaries, as defined by the
Human Protein Atlas34. This analysis reveals that cell-type-
specific domain boundaries and boundaries present in 2 or 3 cell
types are significantly depleted for the presence of housekeeping
genes, and cell-type constitutive boundaries present in 7 cell types
or constitutive to all 8 cell types, are significantly enriched for
housekeeping genes (Fig. 7f).
Discussion
Even though it is established that the architectural protein CTCF
is a master regulator of chromatin conformation35–38, the rela-
tionship between CTCF binding and regulation of long-range
epigenome expression and chromatin conformation is not yet
well established. Due to the ongoing debate about consequences
of CTCF depletion on 3D architecture using different approaches
and cell systems13,14,39,40, we were particularly interested here to
determine if CTCF binding also plays a role in the insulation of
LRES and LREA regions15,16. We therefore explored the genome-
wide chromatin effects of global CTCF depletion in prostate
cancer cells to determine the role of CTCF in long-range
epigenetically regulated domain organisation. We were surprised
to find a conserved subset of CTCF sites that are resistant
to CTCF depletion and propose that these persistent CTCF sites
are essential for constitutive higher order chromatin architecture
and the maintenance of long-range epigenetically regulated
domains.
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We performed ChIP-seq after genome-wide CTCF knockdown
in two different cell types and identified a small subclass of highly
conserved CTCF sites that remain persistently bound despite the
apparent robust loss of CTCF. Indeed we found that persistent
sites were commonly shared across different cell types unlike
lost sites that were more cell-type specific, in line with Schmidt
et al. 41,42. Persistent CTCF sites, relative to all CTCF sites, are
typically less methylated and display more chromatin accessibility
and a higher intensity of CTCF binding suggesting that these
CTCF sites are more consistently bound across a population of
cells. Indeed, we found a remarkably high level of enrichment of
persistent CTCF sites at TAD boundaries that were conserved
across different cell types. This level of conservation suggests a
fundamental role for persistent CTCF sites in constitutive chro-
matin architecture. It has previously been reported that house-
keeping genes are generally enriched at TAD boundaries2 but we
expanded this finding to show that enrichment of housekeeping
genes increases incrementally with the level of conservation of the
boundary. Together, these findings suggest that preferential
retention of persistent CTCF binding is important to preserve the
expression of housekeeping genes and cell viability.
We found that genome-wide depletion of CTCF resulted in the
disruption of TAD insulation in regions that were depleted in
persistent sites, in particular resulting in the merging of TADs. In
contrast, persistent sites were enriched at TAD boundaries that
remain intact following CTCF depletion. This supports our
finding that retention of CTCF binding plays a role in main-
taining TAD structure and thereby protecting against large-scale
changes to gene expression. Other groups studying the con-
sequences of CTCF depletion have previously reported opposing
results demonstrating either major disruption to TAD structure14
or only modest changes13,39. Potentially these differences are due
to the different levels of residual CTCF binding post knockdown.
Our data suggests that the vulnerability of TAD to CTCF inter-
ference is context dependent and that TAD boundaries that are
maintained, lost or gained after CTCF depletion depend on the
distribution of persistent CTCF sites at TAD boundaries.
Finally, we showed that genome-wide CTCF depletion had
little effect on gene expression levels or active chromatin dis-
tribution across the adjacent LRES and LREA domains in the
KLK gene locus in prostate cancer cells. Even though the majority
of CTCF sites across the locus were depleted, binding persisted at
two CTCF sites at the boundary of the LREA and LRES regions.
Strikingly, targeted CRISPR–Cas9n deletion of CTCF persistent
sites at the KLK locus resulted in a change in chromatin looping,
and coordinated activation of the KLK genes contained within the
LRES domain. These results demonstrate the persistent CTCF
sites can play a direct role in the insulation of long-range epi-
genetically regulated domains due to loss of chromatin looping
and potential spreading of gene activation from the LREA region.
Previous locus-specific studies have also shown CTCF protein can
play a role in mediating chromatin folding7,43. Multiple studies
have also shown that CTCF positions cohesin at CTCF sites
across the genome26,44,45. In accordance with this finding we
show that following CTCF knockdown at the KLK region, RAD21
also remains bound at persistent sites but is lost from all other
CTCF sites. This suggests that cohesin preserves its usual func-
tions at this location and thus it is likely that cohesin works in
concert with persistent CTCF to maintain boundaries.
Taken together the data demonstrates that a portion of CTCF
binding persists after CTCF depletion and that these sites are
conserved and located at constitutive TAD boundaries. This
supports a model where there is a preferential order to the loss of
TAD insulation upon CTCF knockdown, where chromatin
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conformation fundamental to cellular viability and long-range
gene expression is preferentially maintained. Our results highlight
the importance of reinterpretation of previous CTCF depletion
studies to determine the genomic landscape and location of the
structural role of the residual CTCFs. Our results support a future
systematic approach to dissect mechanisms regulating key CTCF-
associated spatial control of chromatin architecture and long-
range epigenetic-regulated domains.
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Methods
Cell culture. Prostate cancer cell line—LNCaP, and normal lung fibroblast cell line
—IMR90, were obtained from the American Type Culture Collection (ATCC). All
were cultured under recommended conditions at 37 °C and 5% CO2.
CTCF RNAi. LNCaP were transfected with 20 nM of Dharmacon ON-TARGET
plus pooled non-targeting siRNA (#D-001810-10-20, Dharmacon) or 20 nM of
Dharmacon ON-TARGET plus pooled CTCF siRNA (#LU-020165-00-0010,
Dharmacon) (containing sequences GAUGAAGACUGAAGUAAUG, GGAGAA
AGAAGAAGAGUA, GAAGAUGCCUGCCACUUAC, GAACAGCCCAUAAAC
AUAG) according to the manufacturer-supplied protocol. Following 72 h of
transfection, cells were split and reverse transfected for a further 72 h (144 h).
IMR90 cells were transfected with the aforementioned siRNAs and concentrations,
however the transfection was performed using Lipofectamine RNAiMAX trans-
fection reagent according to the manufacturer's instructions.
Western blots. After 72 and 144 h post-transfection nuclear protein was harvested
by adding 10 mM Tris–HCl, 10 mM NaCl, 3 mM MgCl2, 0.1 mM EDTA and 0.5%
IGEPAL to the cell pellet followed by dounce homogenisation and centrifugation.
The supernatant containing cytoplasmic protein was removed and the remaining
pellet was incubated for 15 min on ice with 400 mN NaCl, 7.5 mM MgCl2, and 0.2
mM EDTA. The suspension was centrifuged and supernatant containing nuclear
protein was collected. Protein concentration was determined using Pierce BCA
Protein Assay Kit. Membranes were developed using Amersham ECL Plus Western
Blotting Detection Reagents and visualised using photographic film. Western blots
used antibodies against CTCF (#07-729, Millipore) diluted 1:5000 and total H3
diluted 1:20,000 (#ab1791, Abcam).
Affymetrix gene ChIP human gene 2.0 ST array. Array carried out by the
Ramaciotti Centre for Genomics. Analysis of Affymetrix expression arrays was
performed using R version 3.2.5. Raw CEL files were read in, background corrected,
quantile normalised and median-polished using RMA46 as implemented in the
“oligo” bioconductor package47. Quality control plots (intensity distributions, RLE
and NUSE plots) were generated and visually inspected to ensure data was of
consistent quality across the experiment. Probesets from the HuGene array were
annotated with Ensembl gene and transcript identifiers using biomaRt48. Differ-
ential expression analysis was performed using limma49. The design matrix used in
linear model fitting included the siRNAs used (CTCF or control), the time point
after siRNA addition (24, 72 or 144 h) and the paired nature of the biological
replicates in the time course. The contrast matrix was constructed to detect dif-
ferences in gene expression between the CTCF and non-targeting siRNA samples
at each time point using moderated t-statistics. Genes were deemed significantly
up-regulated or down-regulated if the Benjamini–Hochberg-adjusted p-value was
<0.05. Distance between differentially expressed genes transcription start sites and
their closest LNCaP CTCF site was calculated using “distanceToNearest” function
in the GenomicRanges Bioconducor package50. Each experiment was performed in
biological duplicate.
ChIP-qPCR and ChIP-seq. Cells were scraped into ice-cold PBS containing pro-
tease inhibitors and collected by centrifugation at 500×g for 5 min at 4 °C. Pellet
was resuspended in ice-cold PBS and fixed with 1% formaldehyde for 15 min at
room temperature. Fixation was quenched with addition of 125 mM (final con-
centration) glycine for 5 min at room temperature. Fixed cells were centrifuged at
500 × g for 5 min at 4 °C and washed 2× with 10 mls ice-cold PBS containing
protease inhibitors. Pellet was resuspended in 1.5 ml nuclei extraction buffer
(10 mM Tris–HCl pH 7.5, 10 mM NaCl, 3 mM MgCl2, 0.1 mM EDTA and 0.5%
IGEPAL) per 10 × 106 cells and incubated on ice for 10 min. Suspension was
dounced 10× with a tight dounce and centrifuged at 1000 × g for 5 min at 4 °C.
Pellet was washed 1× with ice-cold PBS-containing protease inhibitors and cen-
trifuged. Pellet was resuspended in 1x sonication buffer (50 mM Tris–HCl pH 8,
1% SDS, 10 mM EDTA) and fragmented to ~300 bp using a Branson probe
Sonifier. Pelleted DNA was resuspended in 1 ml IP dilution buffer (16.7 mM
Tris–HCl pH 8, 0.01% SDS, 1% Triton X-100, 167 mM NaCl, 1.2 mM EDTA) per
ChIP (each ChIP contains 5 × 106 cells) and pre-cleared with 30 μl of Salmon
Sperm DNA/Protein A agarose–50% Slurry (#16-157, Millipore) per ChIP. 10 μg of
the following antibodies were added per ChIP and incubated overnight—CTCF
(#07-729, Millipore), RAD21 (#ab992, Abcam), H3K4me3 (#39159, Active Motif),
H3K27ac (#39133, Active Motif). Antibody/protein complexes were bound to
Salmon Sperm DNA/Protein A agarose–50% Slurry. The samples were pelleted and
washed once with low salt buffer (2 mM EDTA, 0.1% SDS, 1% Triton X-100,
20 mM Tris–HCl pH 8.1, 150 mM NaCl) once with high salt buffer 2 mM EDTA,
0.1% SDS, 1% Triton X-100, 20 mM Tris–HCl pH 8.1, 500 mM NaCl), once with
LiCl buffer (1 mM EDTA, 10 mM Tris–HCl pH 8.1, 250 mM LiCl, 1% sodium
deoxycholate, 1% IGEPAL) and twice with TE buffer (1 mM EDTA, 10 mM
Tris–HCl pH 8.1). Antibody/protein complexes were eluted off beads using elution
buffer (1% SDS, 100 mM sodium bicarbonate). Crosslinks were reversed with NaCl.
Protein and RNA were degraded with Proteinase K and RNAse A, respectively.
Libraries for ChIP-seq were prepared using TruSeq ChIP sample Preparation Kit
(#IP-202-900, Illumina). For ChIP-seq the resulting libraries were sequenced on
the Illumina HiSeq 2500 platform configured for 50-bp single-end reads. Bowtie151
was used to align ChIP-seq reads to hg19 allowing up to three mismatches, dis-
carding reads mapping to multiple positions in the genome and removing duplicate
reads. Peaks were called using MACS252 or Peak ranger software53 and both bigwig
(signal) and bed (peak calls) files were visualised using the UCSC genome brow-
ser54. For ChIP-qPCR presence of protein binding was assessed using primers
listed in Supplementary Table 1. Each experiment was performed in biological
duplicate.
Low input ChIP-seq. Active Motif Low-Cell ChiP-seq kit was used according to
the manufacturers instructions to perform CTCF ChIP on 35,000 IMR90 cells in
duplicate and to prepare libraries. Libraries were sequenced on Illumina Next-
Seq500 platform configured for 75-bp single-end reads. Fastq file analysis was
performed using a custom pipeline based on a modified version of guidelines for
molecular identifier (MID) analysis for single-read sequencing (Active Motif).
Fastq files were merged by a custom script, adapter trimmed using cutadapt and
read quality was assessed using FastQC. Reads were aligned to the human (hg19)
genome using BWA and the resulting SAM file was sorted and converted into
BAM format. Duplicate reads were identified and removed using custom Perl script
provided by Active Motif. The de-duplicated BAM was used to generate bigwig files
and peak calls with MACS2. The peak output files from MACS2 were then con-
verted to bigwig files for visualisation.
CRISPR–Cas9n. CRISPR–Cas9n (D10A double nickase mutant) editing was per-
formed according to the Nature Method protocol by Ran et al.27 with some
modifications. sgRNAs were designed using the online CRISPR Design Tool
(http://tools.genome-engineering.org). CTCF motifs within the ChIP-seq peaks
were called using HOMER55. Input sequences (Supplementary Table 3) for the
Design tool were obtained from the UCSC genome browser and included the
HOMER CTCF motifs (highlighted in red) within the KLK-persistent sites.
sgRNAs that were immediately adjacent to a protospacer adjacent motif (PAM)
were designed for each persistent site. The BbsI-cloning site (5′ CACC 3′) was
added to the 5′ end of the sgRNAs and oligos (Supplementary Table 4) were
ordered and purchased from Integrated DNA Technologies. Paired 100 μM for-
ward and reverse sgRNAs were phosphorylated and annealed with 1x T4 ligation
buffer with ATP (#B0202S, NEB) and T4 PNK (# M0201S, NEB) using the fol-
lowing conditions: 37 °C for 30 min; 95 °C for 5 min; ramp down to 25 °C at
5 °C/min. Products were then diluted 1:200 in ddH2O. Diluted sgRNA oligos were
each cloned into 100 ng pSpCas9n(BB)-2A-GFP (# PX461, Addgene) using 1x
Tango buffer (#BY5, Thermo Fisher), 10 mM DTT (#18080-093, Invitrogen),
10 mM ATP (#P0756S, NEB). 1 μl Fast Digest BbsI (#FD1014, Thermo Fisher) and
0.5 μl T7 ligase with 2x rapid ligation buffer (#M0318L, NEB). The reaction was
incubated for a total of 60 min in a thermocycler on the following cycle: 37 °C for
5 min, 21 °C for 5 min. Plasmids were transformed into α-Select Chemically
Competent Cells (#BIO-85027, Bioline). 2 μl of plasmids were added to 20 μl of ice-
cold cells and incubated on ice for 1 h. The mixture was heat-shocked at 42 °C for
2 min in a water bath and returned immediately to ice for 5 min. 250 μl of lysogeny
broth (LB) was added to the mixture and incubated at 37 °C for 1 h. Cells were then
streaked onto LB agar plates containing ampicillin and incubated overnight at
37 °C. Three colonies were picked per sgRNA (to increase chances of having
correct insert) and inoculated into a 5 ml culture of LB with 100 μg ml−1 ampi-
cillin. Cultures were grown overnight at 220 rpm at 37 °C. Plasmid DNA was
isolated using QIAGEN Spin Miniprep kit (#27104, Qiagen) following the man-
ufacturer’s instructions. Plasmids were submitted to Australian Genome Research
Facility for sequencing with U6-Fwd promoter (GACTATCATATGCTTACCGT)
and inserts were verified before being used for transfection. 350,000 LNCaP cells
were transfected using 1 μg plasmid and Lipofectamine 3000 (#L3000015, Life
Technolgies). GFP-positive cells were sorted and pooled 24 h after transfection.
Sorted cells were expanded and RNA and chromatin were harvested in biological
duplicate. qPCR was used to determine changes in Kallikrein region gene
expression. Primers are listed in Supplementary Table 5.
3C and Hi-C. Hi-C experiments were based on ref. 4 with some modifications. 10 ×
106 single cells were collected and fixed with 2% methanol-free, formaldehyde for
5 min at room temperature. Reactions were quenched with glycine and incubated
at room temperature for 5 min followed by an additional 10 min on ice. Cells were
centrifuged for 3 min at 500 × g then washed in ice-cold PBS and protease inhi-
bitors followed by an additional centrifugation. Nuclei were extracted by incuba-
tion in 1 ml ice-cold nuclei buffer (10 mM Tris, pH 8, 10 mM NaCl, 0.2% IGEPAL,
plus protease inhibitors) per 10 × 106 cells for 2 h on ice followed by dounce
homogenisation (30× strokes). Nuclei were collected by centrifugation at 4 °C for
10 min at 2500×g then washed twice in 1 × NEBuffer3.1 (#B703S, New England
Biolabs). Nuclei were resuspended in ice-cold 1 × NEBuffer3.1 supplemented with
0.3% SDS then incubated at 37 °C for 1 h with gentle shaking. 1.6% Triton X-100
was added followed by as further 60 min incubation at 37 °C with shaking.
Chromatin was digested overnight with 750U BglII (#R0144S, New England Bio-
labs) at 37 °C with shaking. Ends were repaired and marked with biotin-14-dATP
using Klenow DNA polymerase (#M0210S, New England Biolabs) at 37 °C for 45
min. Samples were centrifuged for 5 min at 600×g and all supernatant removed
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13753-7
10 NATURE COMMUNICATIONS |           (2020) 11:54 | https://doi.org/10.1038/s41467-019-13753-7 | www.nature.com/naturecommunications
except for 50 μl including the pellet. Ligations were performed in a final volume of
950 μl composed of T4 DNA Ligase (#M0292L, New England Biolabs), T4 DNA
Ligase buffer, 1% Triton X-100 and 100 μg BSA. Reactions were performed at 18 °C
for 4 h. Samples were centrifuged once more and supernatant removed before
pellets were resuspended in 1000 μg Proteinase K, 1% SDS and 0.5 M NaCl and
incubated at 65 °C overnight. The DNA was purified twice with phenol:chloroform:
isoamyl alcohol 25:24:1 saturated with 10 mM Tris, pH 8.0, 1 mM EDTA. After the
second extraction, DNA was precipitated with 80% ethanol, 50mM sodium acetate
and 10 μg glycogen overnight at −80 °C. DNA was collected by centrifugation at
18,000 × g for 30min at 4 °C and dissolved in nuclease-free water. Quality of digestion
and ligation was assessed with gel electrophoresis. DNA was quantified using Broad
Range Qubit assay (#Q32854, Life Technologies). For 3C, ligated samples were
assayed by qPCR in quadruplicate. In order to control for PCR efficiency, we digested
and ligated BAC clones that spanned the entire length of the KLK region: CTC-771P3
(Start: Chr19, 51229459, End: Chr19, 51358173) and CTD-2342A18 (Start: Chr19,
51366253, End: Chr19, 51635598) and confirmed equal efficiency for primers with
positive interactions. 3C primers are listed in Supplementary Table 2. For Hi-C,
samples were taken forward to library preparation.
Preparation of Hi-C libraries. Hi-C libraries were prepared using a customised
protocol described by Taberlay et al.56. Hi-C material was sonicated using a Covaris
Focused-Ultrasonicator M220 instrument to achieve fragment sizes of 300–500 bp.
Fragmented DNA had ends repaired using the NEBNext DNA Prep Master Mix Set
for Illumina (#E6040L, NEB). Following end repair a size selection was performed
using 1.6× volume AMPureXP Beads (#A63881, Beckman Coulter Inc.). Next blunt
ends were dA-tailed using the NEB# E6040L kit. This material was added 1:1 to
MyOne Streptavidin C1 beads (#650-01, Invitrogen) that had been resuspended in
2× binding buffer (10mM Tris–HCl pH 8.0, 1 mM EDTA and 2M NaCl) and
incubated for 20min at room temperature, with rotation. Biotin-tagged DNA cou-
pled with MyOne Streptavidin C1 beads was isolated using a magnetic particle
concentrator. Beads were washed once with 200 μl 1× binding buffer and resus-
pended in a final volume of 60 μl of H2O. Adapters were ligated using the NEBNext
Ultra DNA Library Prep kit (#E7370L, NEB). Adapter-ligated DNA was washed 2×
with 200 μl of 1× tween wash buffer (5mM Tris–HCl pH 8.0, 0.5 mM EDTA, 1M
NaCl and 0.05% Tween (#p7949, Sigma Aldrich)), 1× with 200 μl binding buffer and
1× with 200 μl 1× NEB2 buffer (#B7002S, NEB) before beads were resuspended in
30 μl H2O. PCR enrichment of adapter-ligated DNA was performed on DNA bound
to the MyOne Streptavidin C1 beads using NEB kit (# E7370L, NEB). The PCR
cycling steps were 1 cycle at 98 °C for 30 s, 10–14 cycles at 98 °C for 10 s/65 °C for
75 s, 1 cycle at 65 °C for 5 min. Clean up of PCR products was performed using 1x
volume AMPureXP Beads (#A63881, Beckman Coulter) and products were eluted
into 30 μl of nuclease-free H2O. Libraries were quantified using the KAPA Library
Quantification Kit for Illumina platforms (#KP-KK4835, Geneworks). Library-size
quality was assessed using a Bioanalyzer 2100 (Agilent Technologies). Libraries were
sequenced (100 bp paired-end reads) on the HiSeq 2500 (Illumina) according to the
manufacturer’s instructions. We generated 30 × 106 and 101 × 106 valid, mapped
read-pairs for the control and CTCF knockdown samples, respectively. Fit-Hi-C was
used to pool biological replicates for downstream analysis.
Normalisation of Hi-C data. Performed as in Taberlay et al. 56. All Hi-C-seq
libraries were processed through the NGSane framework v0.5.257 available from
Github using the “fastqc”, “hicup” and “fithicaggregate” modules as follows: First,
quality check of sequence libraries was performed with FastQC v0.11.2. Raw fastq
files were then pre-processed, mapped with bowtie v1.1.051 and assessed for
artefact levels through HiCuP v0.5.2 supplying genome assembly (hg19) and the
BglII-restriction enzyme cut site. Aligned read files in BAM format were sorted
with Samtools v1.258 and duplicates were tagged using MarkDuplicates from
Picard tools v1.121. Replicates were pooled using bespoke Python scripts (provided
within NGSane) leveraging the sparse matrices formats in the SciPy libraries
(http://www.scipy.org/). Significant connections were assessed from contact count
matrices at a 40 kb resolution using a custom adaptation of FitHi-C59,60 (provided
within NGSane) supplying iteratively corrected bias offsets calculated through
HiCorrector v1.161 as well as genome mapability tracks from ENCODE. Significant
contacts with false discovery rate (FDR) <0.01 were imported into the WashU
Epigenome Browser62 for visualisation and further analysis.
Identification of topologically associating domains. Performed as in ref. 56.
TADs were identified in the Hi-C-seq data using the ‘domaincaller’ pipeline
developed by Dixon et al. 2. The domaincaller algorithm uses a statistic called the
‘directionality index’ (DI) that quantifies upstream and downstream interaction
bias of 40 kb genomic bins. This was developed based on the observation that the
most upstream portion of a TAD is highly biased towards interacting downstream,
and the downstream portion of a topological domain is highly biased towards
interacting upstream. Hence the DI can be used to locate TADs and TAD
boundaries. A Hidden Markov model (HMM) is used to determine the underlying
directionality bias and uses the assumption that the DI is a mixture of “Upstream
Interaction bias”, “Downstream Interaction bias” or “No bias”. These HMM calls
are used to infer a TAD as a region beginning at a single downstream-biased HMM
state, which continues through any contiguous downstream-biased states and ends
at the last in a series of upstream states. “Domain boundaries” were called as
regions within 100 kb from the TAD and “unorganised chromatin” were regions at
least 100 kb from the TAD.
Visualisation of Hi-C data. Performed as in Taberlay et al. 201656. To visualise the
segmentation of the interaction data into domains, we generated 2D heat maps at
40 kb resolution and overlaid them with previously generated ChIP-seq tracks and
TAD tracks generated as BED files. Interaction frequencies were calculated as
previously described and visualised in the WashU Epigenome Browser62. Positive
score thresholds were adjusted manually to normalise for sequencing depth dif-
ference between control and CTCF RNAi samples.
Domain boundary-enrichment analysis. To determine if domain boundaries were
associated with a given factor (histone marks, CTCF and RAD21), we used ngsplot
(v2.47.1)63 and plotted the averaged data around the ±500 kb region of the
boundary. Additionally, we defined the percentage of overlap between CTCF and
H3K4me3 binding sites and domain boundaries by intersecting peaks identified
from ChIP-seq data with the domain boundaries.
Differential histone mark binding. DiffBind64 was used to identify differential
binding of H3K4me3 and H3K27ac. Peaks were called in each treatment group and
replicate separately using PeakRanger53, merged into a consensus peakset for the
experiment retaining only peaks that occurred in two or more samples, the number
of aligned sequencing reads occurring in each consensus peak in each sample was
then counted. Potential differential binding between the treatment groups was then
assessed using the edgeR method65 and significantly differentially bound peaks
called using an FDR cutoff of 0.01, minimum absolute log2 fold-change of 1 and
minimum peak height of 7 in at least one condition.
Observed/expected enrichment calculation. The observed/expected ratio to
assess the enrichment of the overlap of two sets of genomic regions compared to
genomic background was calculated by assessing the degree of overlap between the
“test” and “query” regions using the “findOverlaps” function in the Genomi-
cRanges Bioconductor package50, and then randomly shuffling the “query” regions
throughout the genome (restricted to autosomes and sex chromosomes) 1000 times
using “shuffleBed” from the BEDTools package66 with the options “-maxTries
10,000 -noOverlapping”.
Housekeeping gene enrichment at arrowhead boundaries. A hyper-geometric
test was used to test for enrichment of housekeeping genes (Human Protein
Atlas34) within sets of genes found within 100 kb of Arrowhead domain borders4
separated by the numbers of cell types they were present in (one– eight cell types).
More specifically, the overlap between housekeeping genes and gene sets was
computed and compared to what would be expected by chance if equivalent
number of genes were drawn uniformly at random from the background set of
genes. We report statistically significant enrichments with Bonferroni-corrected
p-value < 0.05.
Statistical tests for positional-enrichment graphs. Welch two-sample t-test was
performed on the calculated average ‘distance to feature’ for persistent and lost
subsets.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support this study are available from the corresponding author upon
request. The datasets generated and/or analysed during the current study have been
uploaded to the Gene Expression Omnibus repository, GEO number GSE125641.
The source data underlying Figs. 3c, 4c and 5a–c and Supplementary Figs. 5A and 11A
are provided as a Source Data file.
Code availability
The custom code used to analyse the data is available from the corresponding author
upon request.
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